We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Meditation as a Treatment for Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00370929
Recruitment Status : Completed
First Posted : September 1, 2006
Last Update Posted : July 22, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Epileptic seizures may occur at times of stress and commonly increase life stress. This study will evaluate whether meditation improves seizure control and quality of life for individuals with uncontrolled epilepsy.

Condition or disease Intervention/treatment
Epilepsy Behavioral: Meditation

Detailed Description:
Individuals who have uncontrolled epilepsy commonly experience disability, depression, anxiety and injuries from seizures. For such individuals, ideal treatments should improve quality of life through control of seizures and improved emotional state. Meditation with cultivation of emotional balance is known to improve emotional state and may also benefit seizure control in some individuals. In this study, individuals with uncontrolled epilepsy will receive detailed training in meditation to determine whether the training leads to improvements in seizure control and various measures of emotion and quality of life.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Treatment of Epilepsy by Meditation and Cultivation of Emotional Balance
Study Start Date : May 2006
Primary Completion Date : January 2008
Study Completion Date : January 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Epilepsy
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Meditation Behavioral: Meditation


Outcome Measures

Primary Outcome Measures :
  1. Seizure frequency [ Time Frame: 20 weeks ]
  2. Quality of Life [ Time Frame: 20 weeks ]

Secondary Outcome Measures :
  1. Mood [ Time Frame: 20 weeks ]
  2. Affect [ Time Frame: 20 weeks ]
  3. Anxiety [ Time Frame: 20 weeks ]
  4. Sleep quality [ Time Frame: 20 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 6 or more seizures per month
  • ability to participate in meditation
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00370929


Locations
United States, California
Geffen School of Medicine at UCLA
Los Angeles, California, United States, 90095
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Principal Investigator: John Stern, MD University of California, Los Angeles
More Information

Responsible Party: John Stern, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00370929     History of Changes
Other Study ID Numbers: HSPC-06-03-001
First Posted: September 1, 2006    Key Record Dates
Last Update Posted: July 22, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases